Ansbert Gadicke, Director, 10% Owner at Cullinan Oncology, Inc. (CGEM), sold 22,507 shares at $29.16 ($656K) on 2021-09-15, disclosed to the SEC on 2021-09-16.
Open-market sale of $656k CGEM by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.17 | 982 | $29K | 4.4% |
| 2 | $29.17 | 7,106 | $207K | 31.6% |
| 3 | $29.17 | 7,106 | $207K | 31.6% |
| 4 | $29.16 | 888 | $26K | 3.9% |
| 5 | $29.16 | 6,425 | $187K | 28.5% |
| Total | $29.17 avg | 22,507 |
| $656K |
| 100% |
| Filing → |
| ITOS | SELL | 2022-01-06 | $20.9M | — | Filing → |
| ITOS | SELL | 2021-10-14 | $5.2M | — | Filing → |
| ITOS | SELL | 2021-10-05 | $2.2M | — | Filing → |